Health Products

Ketorolac Tromethamine Injection, USP (2015-06-30)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
41526DK
Recalling Firm
Hospira Healthcare Corporation
2600 Boul. Alfred-Nobel, Suite 100
St Laurent
H4S 0A9
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
2600 Boul. Alfred-Nobel, Suite 100
St Laurent
H4S 0A9
Quebec
CANADA
Ketorolac Tromethamine Injection, USPSolutionDIN 02390582Ketorolac Tromethamine 30 mg / mL

Introduction

Recalled Products

Ketorolac Tromethamine Injection, USP

Reason

Potential for presence of particulate matter in the glass vials containing Ketorolac.

Depth of distribution

Wholesalers and Hospitals
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime